了解前列腺癌中的种族差异:一个多方面的方法
Charles Cobbs1, Gregory T Chesnut1,2, Ayesha A Shafi1,3
1Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Cancer medicine
|May 30, 2025
概括
非洲裔美国男性由于基因组,社会经济和系统因素而面临更高的前列腺癌 (PCa) 风险和死亡率. 公平的护理和更多的临床试验参与可以减少这些差异.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 前列腺癌 (PCa) 不成比例地影响非裔美国人 (AA) 的男性,与白人美国人 (CA) 相比,发病率更高,疾病更具侵略性,死亡率增加.
- 这些差异源于基因组,社会经济,环境和系统因素的复杂相互作用.
研究的目的:
- 为了审查前列腺癌多因素原因,AA和CA男性之间的差异.
- 突出明显的生物学差异和不利的社会决定因素,这些因素导致AA男性的结果较差.
- 提出可行的策略,以实现前列腺癌发病率的健康公平.
主要方法:
- 综合基因组,社会经济,环境和系统分析的综合文献综述.
- 检查分子变化,瘤微环境相互作用和健康的社会决定因素.
- 分析来自医疗保健系统的证据,以公平获取为准.
主要成果:
- 在AA男性中,有明显的基因组变异 (例如FOXA1,BRAF,CHD1突变) 和DNA修复缺陷,这表明需要针对特定人群的精准医学.
- 免疫瘤路径和瘤微环境差异有助于AA男性的攻击性疾病表型.
- 不利的社会决定因素,如有限的护理机会,较低的查率和医疗不信任,加剧了差异,尽管公平的待遇可以产生相似的结果.
结论:
- 解决前列腺癌差异需要采取整体方法,针对基因组,社会和系统因素.
- 关键策略包括在临床试验中增加AA的代表性,增强文化能力的护理,改善早期检测的机会,并扩大社区外展.
- 在前列腺癌中实现健康公平需要拆除系统性障碍,并确保所有男性的平等待遇.
相关概念视频
01:25Strategies for Assessing and Addressing Confounding
86
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
86
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334